Executives On The Move: Ambrx Biopharma, Adagio Therapeutics and More
Executive Summary
Recent executive changes in the industry include C-suite changes at Adagio Therapeutics and Clover Biopharmaceuticals. Meanwhile, new directors were appointed at Ambrx Biopharma and CANbridge Pharmaceuticals, among others.